Skip to content
Home

Category: COPD

FDA approves roflumilast for COPD treatment

March 2, 2011 by srrpenna

The FDA has approved a new treatment for people with worsening symptoms of severe chronic obstructive pulmonary disease (COPD), a lung disorder that makes breathing difficult.

The drug, roflumilast -- carrying the trade name Daliresp -- will be sold in pill form, unlike some other medications for COPD, which are inhaled.

COPD Experts Meet to Discuss Immediate Steps to Improve Patient Care

July 7, 2010 by neondrum

July 7 2010 - Today, over 100 of England’s top primary care respiratory healthcare specialists are meeting to discuss the way forward in chronic obstructive pulmonary disease (COPD) management, a condition that kills more people every year in the UK than bowel, breast and prostate cancer. Discussions about the immediate changes needed to improve patient care are in light of the recently published updated National Institute for Health and Clinical Excellence (NICE) COPD guideline and anticipated National Strategy for COPD, expected to be made available later this year.

AdaptiveThemes